查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564107

切片检查设备的全球市场

Biopsy Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球切片检查设备市场预计将达到 59 亿美元

2023 年全球切片检查设备市场预计为 43 亿美元，预计到 2030 年将达到 59 亿美元，2023-2030 年分析期间复合年增长率为 4.5%。超音波引导切片检查是本报告分析的细分市场之一，复合年增长率为 5.4%，预计到分析期结束时将达到 24 亿美元。在分析期间，CT 扫描引导活检领域的复合年增长率估计为 4.8%。

美国市场预计12亿美元，中国预计复合年增长率4.2%

预计 2023 年美国切片检查设备市场规模将达 12 亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 9.247 亿美元，2023-2030 年分析期间复合年增长率为 4.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.5% 和 3.4%。在欧洲，德国的复合年增长率预计为 3.7%。

全球切片检查设备市场—主要趋势和驱动因素总结

切片检查装置为何受到关注？

切片检查设备是诊断过程的核心，尤其是各种癌症的早期检测和监测。切片检查设备的最新技术进步显着提高了其准确性、安全性和患者舒适度。从传统的针活检到先进的影像引导和机器人辅助方法，这些设备的发展令人震惊。这些创新不仅提高了组织采集的精确度，而且最大限度地减少了手术的侵入性，从而缩短了恢復时间并减少了併发症。超音波、MRI 和电脑断层扫描等影像技术与切片检查设备的整合将进一步彻底改变该领域，允许在手术过程中进行即时指导，并确保采集的样本来自最相关的部位，这保证了样本的准确性。收集，从而提高诊断准确性。

最终用户趋势如何影响切片检查设备市场？

由于医疗保健领域最终使用趋势的变化，切片检查设备的使用发生了重大变化。癌症和其他慢性疾病的盛行率不断上升，增加了对早期准确诊断工具的需求。医院和诊断中心是切片检查设备的主要用户，但门诊诊所和癌症中心也越来越多地采用这些技术。这种转变很大程度上是由于对早期检测和个人化医疗的重视所推动的，这需要准确和及时的诊断。此外，世界人口老化和定期健康检查意识的提高正在推动对常规切片检查的需求。虽然这一趋势在医疗基础设施支援先进诊断的已开发国家尤其明显，但新兴市场也在迅速迎头赶上，进一步推动了对这些设备的需求。

哪些创新将塑造切片检查设备的未来？

切片检查设备的未来正在透过旨在改善患者治疗结果和诊断准确性的持续创新来塑造。最重要的发展之一是液态切片是传统切片检查的一种侵入性较小的替代方案。液态切片可分析血液样本中的循环性肿瘤细胞和 DNA，无需手术即可提供有关癌症存在和进展的重要资讯。另一个创新领域是开发一次性切片检查设备，以降低交叉污染和感染的风险。这些仪器在无菌至关重要的环境中尤其有价值。此外，机器人辅助切片检查技术的进步正在提高样本采集的准确性和一致性，减少人为错误，并使更复杂的程序更容易执行。这些创新不仅提高了切片检查过程的效率，而且扩大了切片检查可诊断的疾病范围。

切片检查设备市场成长的驱动力是什么？

切片检查设备市场的成长受到多种因素的推动。癌症和其他慢性病盛行率的上升迫切需要早期准确的诊断，这是市场成长的关键驱动力之一。影像技术的整合和微创切片检查技术的发展等技术进步极大地提高了切片检查的准确性和安全性，使其更容易为患者所接受和接受。此外，个人化医疗的趋势正在推动对精确诊断工具的需求，其中治疗越来越多地根据个人的疾病特定特征进行客製化。此外，新兴市场医疗保健基础设施的扩张正在为引进先进切片检查设备创造新的机会。政府对癌症研究和早期诊断项目的措施和资助也在支持市场成长方面发挥重要作用。随着人们对早期检测重要性的认识不断增强，预计切片检查设备市场将在技术创新和全球医疗保健实践的转变的推动下出现持续的需求。

受访企业范例（共46家）

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10731

Global Biopsy Devices Market to Reach US$5.9 Billion by 2030

The global market for Biopsy Devices estimated at US$4.3 Billion in the year 2023, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Ultrasound-Guided Biopsy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the CT Scan-Guided Biopsy segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 4.2% CAGR

The Biopsy Devices market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$924.7 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Biopsy Devices Market - Key Trends and Drivers Summarized

Why Are Biopsy Devices Gaining Attention?

Biopsy devices have become a cornerstone in the diagnostic process, particularly in the early detection and monitoring of various cancers. Recent technological advancements in biopsy devices have significantly improved their accuracy, safety, and patient comfort. From traditional needle biopsies to advanced image-guided and robotic-assisted techniques, the evolution of these devices is remarkable. These innovations have not only enhanced the precision of tissue sampling but also minimized the invasiveness of the procedure, leading to quicker recovery times and fewer complications. The integration of imaging technologies like ultrasound, MRI, and CT scans with biopsy devices has further revolutionized the field, enabling real-time guidance during the procedure and ensuring that the samples collected are from the most relevant areas, thereby increasing diagnostic accuracy.

How Are End-Use Trends Shaping the Biopsy Devices Market?

The utilization of biopsy devices is seeing a notable shift, driven by changes in end-use trends within the healthcare sector. With the rising incidence of cancer and other chronic diseases, there is an increasing demand for early and accurate diagnostic tools. Hospitals and diagnostic centers are the primary users of biopsy devices, but there’s a growing trend of outpatient clinics and specialized cancer centers adopting these technologies. This shift is largely due to the emphasis on early detection and personalized medicine, which requires precise and timely diagnosis. Moreover, the aging global population, coupled with the growing awareness of regular health check-ups, is driving the demand for routine biopsy procedures. This trend is particularly noticeable in developed regions, where healthcare infrastructure supports advanced diagnostic practices, but emerging markets are quickly catching up, further fueling the demand for these devices.

What Innovations Are Shaping the Future of Biopsy Devices?

The future of biopsy devices is being shaped by continuous innovations aimed at improving patient outcomes and diagnostic accuracy. One of the most significant developments is the advent of liquid biopsies, which offer a less invasive alternative to traditional tissue biopsies. Liquid biopsies analyze circulating tumor cells or DNA from a blood sample, providing crucial information about the presence and progression of cancer without the need for surgery. Another area of innovation is the development of single-use, disposable biopsy devices that reduce the risk of cross-contamination and infection. These devices are particularly valuable in settings where sterility is a top priority. Additionally, advancements in robotic-assisted biopsy procedures are enhancing the precision and consistency of sample collection, reducing human error, and enabling more complex procedures to be performed with greater ease. These innovations are not only improving the efficiency of the biopsy process but are also expanding the range of conditions that can be diagnosed through biopsy.

What’s Driving the Growth in the Biopsy Devices Market?

The growth in the biopsy devices market is driven by several factors. The rising prevalence of cancer and other chronic diseases has led to an urgent need for early and accurate diagnosis, which is one of the primary drivers of market growth. Technological advancements, such as the integration of imaging technologies and the development of less invasive biopsy techniques, have significantly improved the accuracy and safety of biopsies, making them more accessible and acceptable to patients. Additionally, the trend toward personalized medicine is fueling demand for precise diagnostic tools, as treatments are increasingly tailored to the specific characteristics of an individual’s disease. Moreover, the expansion of healthcare infrastructure in emerging markets is creating new opportunities for the adoption of advanced biopsy devices. Government initiatives and funding for cancer research and early diagnosis programs are also playing a crucial role in supporting market growth. As awareness of the importance of early detection continues to grow, the biopsy devices market is expected to experience sustained demand, driven by both technological innovations and shifts in healthcare practices globally.

Select Competitors (Total 46 Featured) -

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biopsy Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Imaging Technologies Propel Growth of Biopsy Devices Market
    • Rising Prevalence of Cancer Spurs Demand for Innovative Biopsy Solutions
    • Emerging Liquid Biopsy Techniques Expand Addressable Market Opportunity
    • Growing Preference for Minimally Invasive Procedures Strengthens Business Case for Biopsy Devices
    • Integration of AI and Machine Learning in Diagnostics Generates Demand for Enhanced Biopsy Devices
    • Aging Population and Increased Cancer Screening Programs Sustain Market Growth
    • Focus on Early Detection Solutions Propels Market Expansion
    • Innovations in Needle Design and Tissue Sampling Methods Drive Product Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopsy Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ultrasound-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for CT Scan-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for MRI-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Steretactics-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Imaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030

IV. COMPETITION